Re-expression of ER in Triple Negative Breast Cancers

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2013 by Emory University
Sponsor:
Collaborators:
Novartis
Eisai Inc.
Information provided by (Responsible Party):
Ruth O'Regan, Emory University
ClinicalTrials.gov Identifier:
NCT01194908
First received: September 1, 2010
Last updated: November 18, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2016
  Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)